Huifeng Niu
1PUBLICATIONS
10CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Mar 27, 2023
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study.Yasutoshi Kuboki, Toshio Shimizu, Kan Yonemori
Pageof 1
Frequent Collaborators
1 joint publications
Yasutoshi Kuboki
1 joint publications
Toshio Shimizu
1 joint publications
Kan Yonemori
1 joint publications
Shunsuke Kondo
1 joint publications
Shigehiro Koganemaru
1 joint publications
Kenichi Harano
1 joint publications
Takafumi Koyama
1 joint publications
Tomoko Yanai
1 joint publications
Toshihiko Doi
1 joint publications
Noboru Yamamoto
![Automated Preparation of [<sup>68</sup>Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=75)